Credicorp Ltd. · BAP · FY2026 Q2 · Calendar Q3 2026
Credicorp raises ROE target as digital growth supports Q2 outlook
Credicorp's Q2 analysis supports a constructive operating thesis: management linked stronger loan growth and digital monetization to higher medium-term ROE ambitions. The thesis remains exposed to credit-cost pressure, El Niño, and regional macroeconomic risks.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about BAP FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management moved from maintaining its outlook to raising the 2026 loan-growth outlook to approximately 12% and lifting the medium-term ROE target to approximately 22%. El Niño risk was quantified through $106 million of additional provisions, while Yape's user base and lending activity continued to expand.
Guidance delta
Management raised the 2026 loan-growth outlook to approximately 12%, lifted the medium-term ROE target from 19.5% to approximately 22%, and forecast fee-income growth in the high teens.
Key takeaways
- Management characterized Q2 as strong, with 20.3% ROE and accelerated loan growth.
- The medium-term ROE target rose to approximately 22%, reflecting management's view of structural and digital improvements.
- Management disclosed $106 million of additional El Niño provisions and said the risk is not expected to affect full-year guidance.
- Yape exceeded 16 million monthly active users, while loan balances grew fourfold year over year.
Management priorities
- Scale Yape lending and increase credit penetration among users.
- Develop the innovation portfolio, including Tenpo and Culqi, to expand fee income.
- Continue investing in technology, data, and talent to improve operating leverage.
Follow BAP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Sep 16, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 17, 2026 |
| HSBC | Buy | Hold | Upgrade | May 19, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 20, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Dec 16, 2024 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jul 7, 2023 |
| Itau BBA | Outperform | Market Perform | Upgrade | Jan 3, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jul 19, 2022 |
| Santander | Hold | Buy | Downgrade | Jun 23, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 7, 2020 |
| Barclays | Overweight | Overweight | Maintain | Mar 15, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 15, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $389.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Thiago Batista | $473 | $368.98 | +21.6% | Aug 20, 2026 |
| Morgan Stanley | Jorge Kuri | $480 | $364.28 | +23.4% | Jun 17, 2026 |
| UBS | Analyst unavailable | $412 | $342.85 | +5.9% | May 26, 2026 |
| HSBC | Carlos Gomez-Lopez | $350 | $303.86 | -10.1% | May 19, 2026 |
| UBS | Thiago Batista | $408 | $340.01 | +4.8% | Apr 21, 2026 |
| UBS | Thiago Batista | $318 | $267.1 | -18.3% | Sep 16, 2025 |
| Morgan Stanley | Jorge Kuri | $195 | $185 | -49.9% | Sep 27, 2024 |
| Bank of America Securities | Ernesto Gabilondo | $190 | $185 | -51.2% | Sep 27, 2024 |
| Bradesco | Gustavo Schroden | $207 | $161.88 | -46.8% | Apr 18, 2024 |
| BTG Pactual | Alonso Aramburu | $154 | $129.38 | -60.4% | Sep 9, 2022 |
Track every rating change on BAP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCredicorp Ltd., together with its subsidiaries, provides various banking services and products in Peru, Bermuda, Colombia, Bolivia, Panama, Chile, the United States, the Cayman Islands, and Mexico. It operates through Universal Banking; Insurance, Medical Services, and Pensions; Microfinance; and Investment Management and Advisory segments. The company grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts. It also issues insurance policies to cover losses in commercial property, transport, marine vessels, automobiles, life, health, and pensions; provides medical and health services, as well as management services of private pension funds to the affiliates.…
Financial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the BAP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-14T16:12:37.263293+00:00
- FN2 earnings calendar · 2026-09-18T01:23:15.369793+00:00
- Polygon adjusted daily market bars · 2026-09-21T14:30:53.228320+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T14:30:53.225381+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.